Primary Trastuzumab Resistance After (Neo) adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice

Chen, XL; Wang, JY; Fan, Y; Luo, Y; Zhang, P; Li, Q; Ma, F; Yuan, P; Chen, SS; Li, Q; Cai, RG; Xu, BH

Xu, BH (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, State Key Lab Mol Oncol,Dept Med Oncol, Beijing 100021, Peoples R China.

CLINICAL BREAST CANCER, 2021; 21 (3): 191

Abstract

Primary trastuzumab resistance after (neo)adjuvant trastuzumab is an important but tough issue. We conducted a retrospective analysis including 1096 p......

Full Text Link